“Poor sleep quality is an overlooked symptom in patients with pulmonary arterial hypertension (PAH), however it may significantly contribute to disease burden”, claim the authors of a study titled “Sleep Quality and Its Predictors among Dyspnea, Fatigue and Exercise Capacity in Pulmonary Arterial Hypertension”, published in Acta Cardiologica. Karen Jacobson-Sive has summarised the key takeaways from this study for the American Journal of Managed Care.
The study shows that poor sleep quality contributes to breathlessness and exercise intolerance in patients with pulmonary arterial hypertension (PAH). Of the 45 patients studied, 64% had poor sleep quality and 86% suffered from severe fatigue. Poor sleep was associated with worse dyspnea and lower exercise capacity, with patients suffering from severe dyspnea being particularly susceptible to sleep disturbances. Surprisingly, severe fatigue was not associated with poor sleep quality. Dyspnea was a strong predictor of sleep quality, regardless of disease severity. The study suggests that treating sleep problems in pulmonary arterial hypertension patients could improve overall disease management.
Karen’s summary is available at this link on the American Journal of Managed Care
The study published in Acta Cardiologica is available at this link in pdf format
Citation
Sleep Quality and Its Predictors among Dyspnea, Fatigue and Exercise Capacity in Pulmonary Arterial Hypertension, Acta Cardiol Sin 2024;40:618626, Raziye Ceylan, Rengin Demir, Melih Zeren, Umit Yasar Sinan and Mehmet Serdar Kucukoglu, doi: 10.6515/ACS.202409_40(5).20240712AA
Many thanks to Deger Kesimoglu for writing up this summary
Photo credit: Shutterstock